Product Information

FUROSEMIDE 40 MG/4 ML VIAL is a generic product labeled by Devatis Inc., priced at $0.2794 per ML under NDC 73043002301. Its NADAC has been published 84 times since Apr 16, 2025.

FDA first approved this application on Apr 2, 2024. Its Orange Book therapeutic-equivalence code is AP.

FUROSEMIDE 40 MG/4 ML VIAL

furosemide
$0.2794per ML

Strength

10 mg/mL

Manufacturer

Devatis Inc.

NDC

73043002301

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAVENOUS

Effective Date

11/18/2026

Active Ingredients

FUROSEMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA215856

FDA Approved

4/2/2024

TE Code

AP

On Market Since

8/10/2024

Pharmacological Classes

Increased Diuresis at Loop of Henle
Loop Diuretic

Price Statistics

The NADAC for FUROSEMIDE 40 MG/4 ML VIAL has been published 84 times since Apr 16, 2025, and over the history we have for it it has risen 21.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2794 per ML
All-time high$0.3500 (May 13, 2026)
All-time low$0.2231 (Jun 18, 2025)
52-week high$0.3500
52-week low$0.2231
Median price$0.2295
Average price$0.2628
Largest weekly change+47.3% (Feb 18, 2026)
Weeks tracked84
Tracking sinceApr 16, 2025

Price History

1W

+5.6%

1M

+10.6%

3M

+5.1%

6M

-18.2%

1Y

+25.2%

3Y

N/A

5Y

N/A

All

+21.7%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FUROSEMIDE 40 MG/4 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for FUROSEMIDE 40 MG/4 ML VIAL, manufactured by Devatis Inc., is $0.2794 per ML (NDC 73043002301), effective Nov 18, 2026.

How has the price of FUROSEMIDE 40 MG/4 ML VIAL changed over time?

Over the history we have for it, the NADAC for FUROSEMIDE 40 MG/4 ML VIAL has risen 21.7%. It has been tracked across 84 weekly CMS publications since Apr 16, 2025.

What are the highest and lowest recorded NADAC prices for FUROSEMIDE 40 MG/4 ML VIAL?

Since Apr 16, 2025, the NADAC for FUROSEMIDE 40 MG/4 ML VIAL has ranged from a low of $0.2231 (Jun 18, 2025) to a high of $0.3500 (May 13, 2026), with a median of $0.2295 per ML.

Are there cheaper alternatives to FUROSEMIDE 40 MG/4 ML VIAL?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FUROSEMIDE 40 MG/4 ML VIAL, is $0.2334 per ML — about 16% below FUROSEMIDE 40 MG/4 ML VIAL.

Who manufactures FUROSEMIDE 40 MG/4 ML VIAL?

FUROSEMIDE 40 MG/4 ML VIAL (NDC 73043002301) is labeled by Devatis Inc., and CMS classifies it as a generic product.